Nihon Kohden Cash Flow from Investing Activities 2015-2024 | NHNKY

Nihon Kohden cash flow from investing activities from 2015 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
Nihon Kohden Annual Cash Flow Investing
(Millions of US $)
2024 $-36
2023 $-57
2022 $-38
2021 $-28
2020 $-42
2019 $-29
2018 $-30
2017 $-57
2016 $-69
2015 $-39
2014 $-43
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.113B $1.538B
Nihon Kohden Corporation is a Japan-based company engaged in the research, development, manufacture and sale of medical electronic equipment, as well as the provision of maintenance and repair services. The Company offers electroencephalograph, electromyography, evoked potential testing equipment, electrocardiographs, cardiac catheterization equipment, diagnostic information systems and related consumables (paper, electrodes, catheters and others), biological information monitors, clinical information systems, artificial respiration, artificial ear, hemocytometer, ultrasonic diagnostic equipment, research equipment and transformers, among others. The Company is also engaged in the sales promotion for its products, as well as the general affair-related and manpower dispatching businesses.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $189.754B 83.11
Thermo Fisher Scientific (TMO) United States $159.887B 19.34
Alcon (ALC) Switzerland $48.486B 32.23
Edwards Lifesciences (EW) United States $44.472B 29.10
IDEXX Laboratories (IDXX) United States $37.951B 43.61
DexCom (DXCM) United States $32.004B 49.47
IQVIA Holdings (IQV) United States $27.061B 14.97
Mettler-Toledo (MTD) United States $22.925B 27.19
STERIS (STE) Ireland $22.088B 25.26
Waters (WAT) United States $20.850B 29.52
SONOVA HOLDING (SONVY) Switzerland $18.568B 0.00
Hologic (HOLX) United States $12.153B 13.11
Sysmex ADR (SSMXY) Japan $11.545B 0.00
Penumbra (PEN) United States $11.463B 89.97
Globus Medical (GMED) United States $9.891B 22.90
Masimo (MASI) United States $8.993B 37.74
Teleflex (TFX) United States $5.586B 9.22
Glaukos (GKOS) United States $5.006B 0.00
Integer Holdings (ITGR) United States $4.385B 22.97
PROCEPT BioRobotics (PRCT) United States $3.077B 0.00
TransMedics (TMDX) United States $3.044B 89.09
Veracyte (VCYT) United States $2.377B 42.75
LivaNova (LIVN) United Kingdom $2.005B 12.14
Elekta AB (EKTAY) Sweden $1.960B 17.62
Alphatec Holdings (ATEC) United States $1.754B 0.00
Tandem Diabetes Care (TNDM) United States $1.431B 0.00
Integra LifeSciences Holdings (IART) United States $1.302B 6.58
Pulse Biosciences (PLSE) United States $1.156B 0.00
OPKO Health (OPK) United States $1.098B 0.00
Artivion (AORT) United States $0.996B 93.32
AxoGen (AXGN) United States $0.780B 0.00
IRadimed (IRMD) United States $0.680B 35.65
Mesa Laboratories (MLAB) United States $0.647B 14.14
RxSight (RXST) United States $0.644B 0.00
SiBone (SIBN) United States $0.595B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.565B 9.10
ORTHOFIX MEDICAL INC (OFIX) United States $0.538B 0.00
OrthoPediatrics (KIDS) United States $0.520B 0.00
Beta Bionics (BBNX) United States $0.513B 0.00
Treace Medical Concepts (TMCI) United States $0.457B 0.00
Delcath Systems (DCTH) United States $0.415B 0.00
ClearPoint Neuro (CLPT) United States $0.404B 0.00
NeuroPace (NPCE) United States $0.392B 0.00
AngioDynamics (ANGO) United States $0.377B 0.00
Semler Scientific (SMLR) United States $0.347B 7.36
Pacific Biosciences Of California (PACB) United States $0.339B 0.00
Tactile Systems Technology (TCMD) United States $0.333B 17.82
Neuronetics (STIM) United States $0.301B 0.00
CVRx (CVRX) United States $0.207B 0.00
908 Devices (MASS) United States $0.200B 0.00
Inogen (INGN) United States $0.194B 0.00
Alpha Tau Medical (DRTS) Israel $0.183B 0.00
LENSAR (LNSR) United States $0.165B 0.00
Spectral Diagnostics (EDTXF) Canada $0.163B 0.00
Anteris Technologies Global (AVR) Australia $0.160B 0.00
Sight Sciences (SGHT) United States $0.158B 0.00
Accuray (ARAY) United States $0.140B 0.00
Lucid Diagnostics (LUCD) United States $0.135B 0.00
KORU Medical Systems (KRMD) United States $0.132B 0.00
Atossa Genetics (ATOS) United States $0.110B 0.00
Rapid Micro Biosystems (RPID) United States $0.102B 0.00
Monogram Orthopaedics (MGRM) United States $0.102B 0.00
Microbot Medical (MBOT) United States $0.083B 0.00
InspireMD (NSPR) Israel $0.083B 0.00
EDAP TMS S.A (EDAP) France $0.082B 0.00
Sensus Healthcare (SRTS) United States $0.071B 10.82
EnVVeno Medical (NVNO) United States $0.062B 0.00
Hyperfine (HYPR) United States $0.054B 0.00
Zomedica (ZOMDF) United States $0.052B 0.00
Positron (POSC) United States $0.050B 0.00
Vicarious Surgical (RBOT) United States $0.049B 0.00
Baird Medical Investment Holdings (BDMD) $0.036B 0.00
Biosig Technologies (BSGM) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Spectral AI (MDAI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Envoy Medical (COCH) United States $0.029B 0.00
NexGel (NXGL) United States $0.020B 0.00
Adagio Medical Holdings (ADGM) United States $0.019B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
PAVmed (PAVM) United States $0.014B 0.00
Accelerate Diagnostics (AXDX) United States $0.013B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.008B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
WORK Medical Technology Group (WOK) China $0.007B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 15.32
Longview Acquisition II (LGV) United States $0.000B 0.00